Inventor · disambiguated record
Mimi L. Quan
Also filed as: ORWAT MICHAEL J · QUAN MIMI · QUAN MIMI L · QUAN MIMI LIFEN
82 granted patents·8 pending applications·2,334 citations·filing 1993–2025
99Inventor score
Files withBRISTOL MYERS SQUIBB CO45BRISTOL MYERS SQUIBB PHARMA CO17DU PONT PHARM CO9DU PONT3DU PONT MERCK PHARMA3
Top patents by PatentIndex Score
90 records- 0198US6187797B1Phenyl-isoxazoles as factor XA InhibitorsDU PONT PHARM CO·Filed 1997·Granted Feb 13, 2001·171 cites·27 claims
- 0298US6020357ANitrogen containing heteroaromatics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1997·Granted Feb 1, 2000·353 cites·72 claims
- 0398US5998424AInhibitors of factor Xa with a neutral P1 specificity groupDU PONT PHARM CO·Filed 1998·Granted Dec 7, 1999·163 cites·23 claims
- 0497US7459564B2Substituted biaryl compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 2, 2008·26 cites·14 claims
- 0597US6989391B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 24, 2006·59 cites·35 claims
- 0697US6602895B2Inhibitors of factor Xa with a neutral P1 specificity groupBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 5, 2003·80 cites·18 claims
- 0797US6339099B1Guanidine mimics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1998·Granted Jan 15, 2002·128 cites·40 claims
- 0897US6060491A6-membered aromatics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1998·Granted May 9, 2000·107 cites·15 claims
- 0996US6967208B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 22, 2005·100 cites·103 claims
- 1096US6548512B1Nitrogen containing heteroaromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 15, 2003·75 cites·52 claims
- 1196US6403620B1Inhibitors of factor Xa with a neutral P1 specificity groupFiled 1999·Granted Jun 11, 2002·91 cites·15 claims
- 1295US8367709B2Dipeptide analogs as coagulation factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 5, 2013·42 cites·11 claims
- 1395US6569874B1Thiazoles as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 27, 2003·40 cites·45 claims
- 1494US7453002B2Five-membered heterocycles useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 18, 2008·24 cites·17 claims
- 1594US7371761B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 13, 2008·12 cites·26 claims
- 1694US7129264B2Biarylmethyl indolines and indoles as antithromboembolic agentsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 31, 2006·88 cites·30 claims
- 1793US6995172B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Feb 7, 2006·19 cites·9 claims
- 1892US8828983B2Macrocycles as factor XIa inhibitorsQUAN MIMI L·Filed 2011·Granted Sep 9, 2014·13 cites·14 claims
- 1992US6207697B1Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor XaDU PONT PHARM CO·Filed 1998·Granted Mar 27, 2001·73 cites·15 claims
- 2091US10487086B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 26, 2019·3 cites·9 claims
- 2191US8940720B2Macrocycles as factor XIa inhibitorsCORTE JAMES R·Filed 2011·Granted Jan 27, 2015·6 cites·4 claims
- 2291US7626039B2Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 1, 2009·14 cites·14 claims
- 2391US6599926B2Heteroaryl-phenyl substituted factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 29, 2003·37 cites·21 claims
- 2491US6429205B1Nitrogen containing heterobicycles as factor Xa inhibitorsBRISTOL MEYERS SQUIBB PHARMA C·Filed 2000·Granted Aug 6, 2002·32 cites·21 claims
- 2590US7645799B2Substituted biaryl compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 12, 2010·7 cites·16 claims
- 2690US6750225B21,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMS CO·Filed 2002·Granted Jun 15, 2004·35 cites·65 claims
- 2789US9802939B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 31, 2017·3 cites·9 claims
- 2889US5886191AAmidinoindoles, amidinoazoles, and analogs thereofDU PONT PHARM CO·Filed 1997·Granted Mar 23, 1999·48 cites·8 claims
- 2988US6043257AAmidinoindoles, amidinoazoles, and analogs thereofDU PONT·Filed 1998·Granted Mar 28, 2000·40 cites·7 claims
- 3087US7235575B2Guanidine mimics as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 26, 2007·4 cites·21 claims
- 3187US6906070B2Guanidine mimics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jun 14, 2005·13 cites·18 claims
- 3287US6552042B2Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor XaBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Apr 22, 2003·20 cites·27 claims
- 3387US6506771B2Heteroaryl-phenyl heterobicyclic factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jan 14, 2003·35 cites·36 claims
- 3486US11136327B2Macrocycles as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·1 cites·11 claims
- 3586US9453029B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·2 cites·13 claims
- 3686US7138412B2Tetrahydroquinoline derivatives useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 21, 2006·25 cites·30 claims
- 3786US6716841B2Nitrogen containing heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Apr 6, 2004·24 cites·18 claims
- 3885US9079918B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 14, 2015·2 cites·12 claims
- 3984US6951872B2Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Oct 4, 2005·14 cites·21 claims
- 4084US6057342AAmidinophenyl-pyrrolidines, -pyrrolines, and -isoxazolidines and derivatives thereofDUPONT PHARMACEUTICAL CO·Filed 1997·Granted May 2, 2000·44 cites·19 claims
- 4183US7842708B2Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 30, 2010·4 cites·16 claims
- 4283US6962935B2Oxygen or sulfur containing heteroaromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2003·Granted Nov 8, 2005·10 cites·36 claims
- 4383US6949550B2Substituted amino methyl factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Sep 27, 2005·13 cites·40 claims
- 4482US8101778B2Five-membered heterocycles useful as serine protease inhibitorsHANGELAND JON J·Filed 2008·Granted Jan 24, 2012·5 cites·2 claims
- 4582US5512681AAngiotensin II receptor blocking imidazolinone derivativesDU PONT·Filed 1993·Granted Apr 30, 1996·53 cites·11 claims
- 4680US12404274B2Macrocycles as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 4779US12187699B2GSPT1 compounds and methods of use of the novel compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Granted Jan 7, 2025·0 cites·2 claims
- 4879US8324199B2Pyridazine derivatives as factor xia inhibitorsCORTE JAMES R·Filed 2009·Granted Dec 4, 2012·4 cites·9 claims
- 4979US6413980B1Nitrogen containing heterobicycles as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 1999·Granted Jul 2, 2002·41 cites·78 claims
- 5078US6730689B2N-[4-(1H-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 4, 2004·9 cites·10 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mimi L. Quan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →